News

Unlocking the power of immune cells: discover how they’re transforming inhalation toxicology

Immune cells are reshaping inhalation toxicology by offering deeper insights into respiratory and systemic effects of tested compounds. In the second ImmuBYTES webinar, ‘Immune cells as predictive tool for toxicology’, Dr. Ewelina Hoffman highlighted the crucial role of alveolar macrophages in improving preclinical safety assessments. Key highlights include: 1. Immune cells & alveolar macrophages As […]

Unlocking the power of immune cells: discover how they’re transforming inhalation toxicology Read More »

ImmuONE raises £600K in investment for ‘3D lung’ to replace animal testing

A UK biotech start-up with a 3D human lung model that provides an alternative to animal testing has raised a further £600,000 from the Midlands Engine Investment Fund, Mercia Ventures and Pioneer Group. ImmuONE’s laboratory model is used to test new drugs, chemicals or consumer products to provide evidence they are safe to use. The

ImmuONE raises £600K in investment for ‘3D lung’ to replace animal testing Read More »

Scroll to Top